• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

清肠汤保留灌肠可诱导左侧溃疡性结肠炎的临床及黏膜缓解:一例报告

Qingchang decoction retention enema may induce clinical and mucosal remission in left-sided ulcerative colitis: A case report.

作者信息

Li Pei-Han, Tang Yu, Wen Hong-Zhu

机构信息

Department of Gastroenterology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.

Department of Basic Medicine, Fudan University, Shanghai 200032, China.

出版信息

World J Clin Cases. 2022 Apr 16;10(11):3573-3578. doi: 10.12998/wjcc.v10.i11.3573.

DOI:10.12998/wjcc.v10.i11.3573
PMID:35582052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9048555/
Abstract

BACKGROUND

Ulcerative colitis (UC) is a chronic autoimmune disease characterized by relapsing-remitting abdominal pain, diarrhea, mucopurulent discharge and rectal bleeding. To date, the etiology of the disease remains unknown; therefore, medical therapy is not yet available. Left-sided UC is mainly treated with oral and topical mesalazine. However, due to its modest clinical effect, endoscopic mucosal remission is not achieved in all patients.

CASE SUMMARY

A 44-year-old man presented to Longhua Hospital with a history of left-sided UC for more than 6 years and slight bloody diarrhea over time. Endoscopy suggested hyperemia, edema, and erosive mucosa involving the rectum and sigmoid colon. The Traditional Chinese medicine Qingchang decoction (QCD) enema treatment was initiated once a day combined with a previous standard dose of mesalazine for 8 wk, and rectal bleeding ceased after 4 wk of treatment. Another QCD enema treatment was provided after symptom relapse due to drug withdrawal for nearly 6 mo. At the 2-mo follow-up, the colonoscopy results indicated mucosal healing with no erosion or ulcers.

CONCLUSION

The Chinese formula QCD retention enema represents a potential treatment for left-sided UC with predominant rectal bleeding to achieve clinical and mucosal remission.

摘要

背景

溃疡性结肠炎(UC)是一种慢性自身免疫性疾病,其特征为反复发作的腹痛、腹泻、黏液脓性分泌物及直肠出血。迄今为止,该病的病因仍不明;因此,尚无特效药物治疗。左侧溃疡性结肠炎主要采用口服和局部应用美沙拉嗪治疗。然而,由于其临床效果一般,并非所有患者都能实现内镜下黏膜缓解。

病例摘要

一名44岁男性因左侧溃疡性结肠炎病史6年余,且长期有轻度便血,就诊于龙华医院。内镜检查提示直肠和乙状结肠黏膜充血、水肿及糜烂。采用中药清肠汤(QCD)灌肠治疗,每日1次,联合之前标准剂量的美沙拉嗪,持续8周,治疗4周后直肠出血停止。因停药近6个月症状复发后,再次给予QCD灌肠治疗。在2个月的随访中,结肠镜检查结果显示黏膜愈合,无糜烂或溃疡。

结论

中药方剂QCD保留灌肠是治疗以直肠出血为主的左侧溃疡性结肠炎、实现临床和黏膜缓解的一种潜在治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fc/9048555/d5ba9ec0140b/WJCC-10-3573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fc/9048555/dff28edca413/WJCC-10-3573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fc/9048555/d5ba9ec0140b/WJCC-10-3573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fc/9048555/dff28edca413/WJCC-10-3573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fc/9048555/d5ba9ec0140b/WJCC-10-3573-g002.jpg

相似文献

1
Qingchang decoction retention enema may induce clinical and mucosal remission in left-sided ulcerative colitis: A case report.清肠汤保留灌肠可诱导左侧溃疡性结肠炎的临床及黏膜缓解:一例报告
World J Clin Cases. 2022 Apr 16;10(11):3573-3578. doi: 10.12998/wjcc.v10.i11.3573.
2
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
3
Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.口服和直肠美沙拉嗪联合治疗轻中度活动期溃疡性结肠炎:快速缓解症状和提高生活质量。
J Crohns Colitis. 2014 Mar;8(3):200-7. doi: 10.1016/j.crohns.2013.08.007. Epub 2013 Sep 4.
4
Typical ulcerative colitis treated by herbs-partitioned moxibustion: A case report.中药隔物灸治疗典型溃疡性结肠炎1例报告
World J Clin Cases. 2020 Apr 26;8(8):1515-1524. doi: 10.12998/wjcc.v8.i8.1515.
5
Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.美沙拉嗪泡沫剂(莎尔福泡沫剂)治疗活动期远端溃疡性结肠炎。与莎尔福灌肠剂的对比试验。SAF - 3研究组。
Ital J Gastroenterol Hepatol. 1999 Nov;31(8):677-84.
6
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.口服及局部使用5-氨基水杨酸(美沙拉嗪)诱导和维持轻度至中度溃疡性结肠炎复发缓解:一项为期一年的随机多中心试验
Dig Liver Dis. 2002 Nov;34(11):787-93. doi: 10.1016/s1590-8658(02)80072-x.
7
A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial.一种新型美沙拉嗪凝胶灌肠剂治疗左侧溃疡性结肠炎:一项随机对照多中心试验
Aliment Pharmacol Ther. 1999 Mar;13(3):381-8. doi: 10.1046/j.1365-2036.1999.00482.x.
8
Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis.清热除湿疗法治疗活动期溃疡性结肠炎的疗效和安全性:网状 Meta 分析。
PLoS One. 2021 Sep 20;16(9):e0257599. doi: 10.1371/journal.pone.0257599. eCollection 2021.
9
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.美沙拉嗪直肠混悬液治疗活动期远端溃疡性结肠炎的早期症状反应和黏膜愈合-两项对照研究的补充结果。
Aliment Pharmacol Ther. 2011 Oct;34(7):747-56. doi: 10.1111/j.1365-2036.2011.04800.x. Epub 2011 Aug 16.
10
Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing.美沙拉嗪治疗左半结肠炎:来自 PODIUM 试验维持缓解和黏膜愈合疗效分析。
J Crohns Colitis. 2012 May;6(4):476-82. doi: 10.1016/j.crohns.2011.10.006. Epub 2011 Nov 10.

引用本文的文献

1
Abdominal Pain in Inflammatory Bowel Disease-Epidemiology, Pathophysiology, and Management: A Narrative Review.炎症性肠病中的腹痛——流行病学、病理生理学及管理:一项叙述性综述
Pain Ther. 2024 Dec;13(6):1447-1469. doi: 10.1007/s40122-024-00672-9. Epub 2024 Oct 28.

本文引用的文献

1
ACG Clinical Guideline: Ulcerative Colitis in Adults.ACG 临床指南:成人溃疡性结肠炎。
Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152.
2
Qingchang Suppository Ameliorates Colonic Vascular Permeability in Dextran-Sulfate-Sodium-Induced Colitis.清肠栓改善葡聚糖硫酸钠诱导的结肠炎中结肠血管通透性
Front Pharmacol. 2018 Oct 31;9:1235. doi: 10.3389/fphar.2018.01235. eCollection 2018.
3
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
靛蓝天然物在溃疡性结肠炎患者多中心随机对照试验中的疗效。
Gastroenterology. 2018 Mar;154(4):935-947. doi: 10.1053/j.gastro.2017.11.024. Epub 2017 Nov 22.
4
Effects of indigo naturalis on colonic mucosal injuries and inflammation in rats with dextran sodium sulphate-induced ulcerative colitis.青黛对葡聚糖硫酸钠诱导的溃疡性结肠炎大鼠结肠黏膜损伤及炎症的影响。
Exp Ther Med. 2017 Aug;14(2):1327-1336. doi: 10.3892/etm.2017.4701. Epub 2017 Jun 28.
5
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.《欧洲溃疡性结肠炎诊断与管理循证共识(第三版)。第二部分:当前管理》
J Crohns Colitis. 2017 Jul 1;11(7):769-784. doi: 10.1093/ecco-jcc/jjx009.
6
Indole compounds may be promising medicines for ulcerative colitis.吲哚类化合物可能是治疗溃疡性结肠炎的有前景的药物。
J Gastroenterol. 2016 Sep;51(9):853-61. doi: 10.1007/s00535-016-1220-2. Epub 2016 May 9.
7
Ulcerative colitis-associated colorectal cancer.溃疡性结肠炎相关结直肠癌
World J Gastroenterol. 2014 Nov 28;20(44):16389-97. doi: 10.3748/wjg.v20.i44.16389.
8
Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing.美沙拉嗪治疗左半结肠炎:来自 PODIUM 试验维持缓解和黏膜愈合疗效分析。
J Crohns Colitis. 2012 May;6(4):476-82. doi: 10.1016/j.crohns.2011.10.006. Epub 2011 Nov 10.
9
Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.临床试验:对照、开放、随机、多中心研究,比较布地奈德或美沙拉嗪灌肠剂对活动期左半结肠炎患者生活质量、安全性和疗效的影响。
Aliment Pharmacol Ther. 2010 Aug;32(3):368-76. doi: 10.1111/j.1365-2036.2010.04354.x. Epub 2010 May 11.
10
Composition of Indigo naturalis.青黛的成分。
Planta Med. 2009 Jun;75(8):860-3. doi: 10.1055/s-0029-1185447. Epub 2009 Mar 18.